Literature DB >> 21928222

[New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland. Polish Cardiac Society statement].

Dariusz Dudek1, Krzysztof J Filipiak, Janina Stępińska, Artur Dziewierz, Andrzej Budaj, Maciej Lesiak, Adam Witkowski, Wiktor Kuliczkowski, Grzegorz Opolski, Waldemar Banasiak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21928222

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN： 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  4 in total

1.  Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience.

Authors:  Tomasz Rakowski; Artur Dziewierz; Zbigniew Siudak; Paweł Kleczyński; Jacek S Dubiel; Dariusz Dudek
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

Review 2.  Significance of antiplatelet therapy in emergency myocardial infarction treatment.

Authors:  Anna Komosa; Maciej Lesiak; Andrzej Siniawski; Tatiana Mularek-Kubzdela; Stefan Grajek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-03-23       Impact factor: 1.426

3.  The influence of pre-hospital medication administration in ST-elevation myocardial infarction patients on left ventricular ejection fraction and intra-hospital death.

Authors:  Magdalena Żurowska-Wolak; Michał Owsiak; Stanisław Bartuś; Marcin Mikos
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-03-27       Impact factor: 1.426

4.  Contemporary use of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry.

Authors:  Tomasz Rakowski; Zbigniew Siudak; Artur Dziewierz; Krzysztof Plens; Paweł Kleczyński; Dariusz Dudek
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.